John Cassels | Fieldfisher

John Cassels is a partner and co-head of the Regulatory Group at Fieldfisher. He specialises in competition law and risk management.

john.cassels@fieldfisher.com

Regulation

No more faux five stars: CMA launches fake reviews investigations

April 14, 2026

CMA warns that manipulating review collection, weighting, or display can mislead consumers and may violate the DMCCA’s new ban on certain review practices.

“GRIP is invaluable for updates on SEC and FINRA actions.”

Unlimited access for 4 weeks. No payment details required. Start free trial

Latest News

The GRIP Files: Esther Mayr, Senior Managing Director, FTI Consulting

PMCPA case highlights UK pharma compliance risks in comms with health pros

FCA’s new rules on NFM: Social media and the right to offend

Latest News

Medicare drug pricing plan could depend on limited international data

CMS issues state toolkit on autism therapy oversight for Medicaid and CHIP programs

HRSA health centers deliver ‘record-breaking’ care to 32.7 million patients

Latest News

AI agents cheated to hack Hugging Face, Open AI reveals at Black Hat event

You talkin' to me? Operationalizing EU AI Act transparency obligations

DOJ’s bulk sensitive personal data rule: Life sciences compliance

Latest News

Moves and hires July 2026

What needs the biggest evolution – communications or trade surveillance?

Nekia Hackworth discusses the SEC's history-making rule proposals in 2026

Latest News

The GRIP Files: Esther Mayr, Senior Managing Director, FTI Consulting

AI agents cheated to hack Hugging Face, Open AI reveals at Black Hat event

Medicare drug pricing plan could depend on limited international data

John Cassels | Fieldfisher

No more faux five stars: CMA launches fake reviews investigations